
Performs analytical chemistry research and experiments in collaboration with others to develop assays based on new and existing methodologies.
Assists in developing and validating oligonucleotide and enzyme testing methodology used to control raw materials, production intermediates, and final products.
Evaluates and optimizes test methods, new antibodies, enzymes, and reagents.
Helps establish, validate and document new or existing compound identification methods.
Conducts testing of analytical samples in support of Process Development.
Conducts work in compliance with cGMP, safety and regulatory requirements.
May provide analysis and evaluation of material and products at all stages of development process Writes and reviews product instructions for use, protocols and technical reports in compliance with Quality Management Systems and Good Laboratory Practices.
Maintains laboratory notebooks and provide customer and co-worker technical support.
Bachelor's or Master's Degree or equivalent.
Post-graduate, certification, and/or license may be required.
8+ years relevant experience for entry to this level.
Additional Details
This job has a full time weekly schedule. Applications for this job will be accepted until at least May 22, 2026 or until the job is no longer posted.The full-time equivalent pay range for this position is $100,720.00 - $157,375.00/yr plus eligibility for bonus, stock and benefits. Our pay ranges are determined by role, level, and location. Within the range, individual pay is determined by work location and additional factors, including job-related skills, experience, and relevant education or training. During the hiring process, a recruiter can share more about the specific pay range for a preferred location. Pay and benefit information by country are available at: https://careers.agilent.com/locationsAgilent Technologies, Inc. is an Equal Employment Opportunity and merit-based employer that values individuals of all backgrounds at all levels. All individuals, regardless of personal characteristics, are encouraged to apply. All qualified applicants will receive consideration for employment without regard to sex, pregnancy, race, religion or religious creed, color, gender, gender identity, gender expression, national origin, ancestry, physical or mental disability, medical condition, genetic information, marital status, registered domestic partner status, age, sexual orientation, military or veteran status, protected veteran status, or any other basis protected by federal, state, local law, ordinance, or regulation and will not be discriminated against on these bases. Agilent Technologies, Inc., is committed to creating and maintaining an inclusive in the workplace where everyone is welcome, and strives to support candidates with disabilities. If you have a disability and need assistance with any part of the application or interview process or have questions about workplace accessibility, please email job_posting@agilent.com or contact +1-262-754-5030. For more information about equal employment opportunity protections, please visit www.agilent.com/en/accessibility.
Occasional
Day
No End Date
R&D

Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio.
Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories.
Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life.
In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.